These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 29679908

  • 1. Recent advances in colony stimulating factor-1 receptor/c-FMS as an emerging target for various therapeutic implications.
    Kumari A, Silakari O, Singh RK.
    Biomed Pharmacother; 2018 Jul; 103():662-679. PubMed ID: 29679908
    [Abstract] [Full Text] [Related]

  • 2. Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases.
    Xiang C, Li H, Tang W.
    Pharmacol Res; 2023 Jan; 187():106566. PubMed ID: 36423789
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression.
    Kirma N, Hammes LS, Liu YG, Nair HB, Valente PT, Kumar S, Flowers LC, Tekmal RR.
    Cancer Res; 2007 Mar 01; 67(5):1918-26. PubMed ID: 17332318
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Engineering a monomeric variant of macrophage colony-stimulating factor (M-CSF) that antagonizes the c-FMS receptor.
    Zur Y, Rosenfeld L, Bakhman A, Ilic S, Hayun H, Shahar A, Akabayov B, Kosloff M, Levaot N, Papo N.
    Biochem J; 2017 Jul 20; 474(15):2601-2617. PubMed ID: 28655719
    [Abstract] [Full Text] [Related]

  • 7. Expression of M-CSF and its receptor (C-FMS) during factor-independent cell line evolution from hematopoietic progenitor cells cocultivated with gamma irradiated marrow stromal cell lines.
    Greenberger JS, Sakakeeny MA, Leif J, Anklesaria P, Pierce JH, Shadduck RK.
    Leukemia; 1992 Jul 20; 6(7):626-33. PubMed ID: 1385639
    [Abstract] [Full Text] [Related]

  • 8. Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors.
    El-Gamal MI, Al-Ameen SK, Al-Koumi DM, Hamad MG, Jalal NA, Oh CH.
    J Med Chem; 2018 Jul 12; 61(13):5450-5466. PubMed ID: 29293000
    [Abstract] [Full Text] [Related]

  • 9. Blocking of the Ubiquitin-Proteasome System Prevents Inflammation-Induced Bone Loss by Accelerating M-CSF Receptor c-Fms Degradation in Osteoclast Differentiation.
    Lee K, Kim MY, Ahn H, Kim HS, Shin HI, Jeong D.
    Int J Mol Sci; 2017 Sep 25; 18(10):. PubMed ID: 28946669
    [Abstract] [Full Text] [Related]

  • 10. FMS Kinase Inhibitors: Current Status and Future Prospects.
    El-Gamal MI, Anbar HS, Yoo KH, Oh CH.
    Med Res Rev; 2013 May 25; 33(3):599-636. PubMed ID: 22434539
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin.
    Pass HI, Lavilla C, Canino C, Goparaju C, Preiss J, Noreen S, Blandino G, Cioce M.
    Oncotarget; 2016 Aug 30; 7(35):56408-56421. PubMed ID: 27486763
    [Abstract] [Full Text] [Related]

  • 12. CSF-1 signaling in macrophages: pleiotrophy through phosphotyrosine-based signaling pathways.
    Mouchemore KA, Pixley FJ.
    Crit Rev Clin Lab Sci; 2012 Aug 30; 49(2):49-61. PubMed ID: 22468857
    [Abstract] [Full Text] [Related]

  • 13. Human monocyte-derived dendritic cells produce macrophage colony-stimulating factor: enhancement of c-fms expression by interleukin-10.
    Rieser C, Ramoner R, Böck G, Deo YM, Höltl L, Bartsch G, Thurnher M.
    Eur J Immunol; 1998 Aug 30; 28(8):2283-8. PubMed ID: 9710206
    [Abstract] [Full Text] [Related]

  • 14. The carboxy-terminal catalytic domain of the GTPase-activating protein inhibits nuclear signal transduction and morphological transformation mediated by the CSF-1 receptor.
    Bortner DM, Ulivi M, Roussel MF, Ostrowski MC.
    Genes Dev; 1991 Oct 30; 5(10):1777-85. PubMed ID: 1717344
    [Abstract] [Full Text] [Related]

  • 15. A novel 110 kDa form of myosin XVIIIA (MysPDZ) is tyrosine-phosphorylated after colony-stimulating factor-1 receptor signalling.
    Cross M, Csar XF, Wilson NJ, Manes G, Addona TA, Marks DC, Whitty GA, Ashman K, Hamilton JA.
    Biochem J; 2004 May 15; 380(Pt 1):243-53. PubMed ID: 14969583
    [Abstract] [Full Text] [Related]

  • 16. Recognition of activated CSF-1 receptor in breast carcinomas by a tyrosine 723 phosphospecific antibody.
    Flick MB, Sapi E, Perrotta PL, Maher MG, Halaban R, Carter D, Kacinski BM.
    Oncogene; 1997 May 29; 14(21):2553-61. PubMed ID: 9191055
    [Abstract] [Full Text] [Related]

  • 17. Conditional deletion of the colony stimulating factor-1 receptor (c-fms proto-oncogene) in mice.
    Li J, Chen K, Zhu L, Pollard JW.
    Genesis; 2006 Jul 29; 44(7):328-35. PubMed ID: 16823860
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.